Revenue and net income soared 81% and 79% year-over-year, fueled by strong product sales and new launches in robotics and medical devices. Leadership transition and board expansion signal strategic continuity, while robust margins and cash position support optimism for sustained growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.